Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

Maturation Inhibitor BMS-955176: Integrated Model of Polymorphic Antiviral Responses

By Enthusiast Inc MDFebruary 16, 2016

HIV-1 maturation inhibitors (MIs) disrupt the final step in the HIV-1 protease-mediated cleavage of the Gag polyprotein, between capsid (CA) and spacer peptide 1 (SP1), leading to the production of…

BLOCKADE OF IFNAR RESCUES ANTI-HIV-1 CD8 T CELL FUNCTIONS TO REDUCE HIV-1 RESERVOIR

By Enthusiast Inc MDMarch 5, 2018

…HIV-1 Gag peptide pool stimulation followed with IL-2/IFN-γ/TNF-α intracellular staining. Transcriptome analyses by RNA-seq were performed with purified human CD8 T cells to identify pathways and genes contributing to IFN-I-induced…

IMMUNE RESPONSES FOLLOWING ANTI-PD-1 MONOCLONAL ANTIBODY INFUSION IN PERSONS WITH HIV

By Jimmy He PharmD, DScApril 4, 2022

…(PWH) in ACTG A5370. Using flow cytometry, we evaluated changes in CD4+ and CD8+ T cell polyfunctional responses (?2) to HIV peptide pools by measuring intracellular expression of CD107a, IFN?,…

Combination CAR T-Cell Therapy Restricts HIV Escape and Durably Suppresses HIV Replication In Vivo

By Jimmy He PharmD, DScMarch 6, 2024

…isolates. Methods: A panel of 4-1BB costimulated CAR T cells expressing 18 distinct bNAb-based CARs were generated against all well-characterized epitopes on HIV Env: V1/V2 apex, V3-glycan supersite, CD4 binding…

TCF-1 EXPRESSION IS ASSOCIATED WITH HIV-SPECIFIC CD8+ T CELL PROLIFERATIVE CAPACITY

By Enthusiast Inc MDMarch 6, 2018

…(TCF-1, Tbet), effector molecules (Granzyme B, Perforin), and surface proteins (PD-1, CD127, CCR7). Proliferation of the tetramer+ population was measured after 6-day in vitro peptide stimulation of CellTraceViolet (CTV)-labeled cells….

MARKERS OF HIV RESERVOIR SIZE IN INFECTED CHILDREN ON LONG-TERM VIRAL CONTROL

By Jimmy He PharmD, DScApril 27, 2020

…mononuclear cells (PBMC) were measured by real-time PCR. Flow cytometry was used to investigate CD4 T cells for 1) co-expression of PD1 with IA (ICOS, CD38, Ki67 and HLA-DR); 2)…

INCLUDING Env IN AN HIV THERAPEUTIC VACCINE BLUNTS Gag/Pol-SPECIFIC T-CELL RESPONSES

By Jimmy He PharmD, DScApril 4, 2022

T cell-based therapeutic vaccination is a potential approach to achieving durable control of HIV. It is assumed, but has not been thoroughly evaluated, that inclusion of Env antigens in a…

SARCOPENIA, FRAILTY, NUTRITION, AND HCV INFECTION AMONG OLDER PEOPLE WITH HIV

By Jimmy He PharmD, DScMarch 3, 2023

…total of 407 participants (277 PLWH and 130 controls) were included; 36% were female. Median age was 55 (interquartile range (IQR): 52-60) years and median duration of ART was 16…

HUMAN PAPILLOMA VIRUS INFECTION PREVALENCE AMONG WOMEN LIVING WITH HIV IN ETHIOPIA

By Jimmy He PharmD, DScMarch 3, 2023

Background: Cervical cancer is the second most reported cancer (13%) among women aged 15-49 years old in Ethiopia. Human papilloma virus (HPV) types 16 and 18 are associated with about…

943 – Ten Million Needed on LA-PrEP to Achieve Significant Effect on Worldwide HIV Epidemic

By Jimmy He PharmD, DScMarch 31, 2026

…$25/year. Methods The UNAIDS Spectrum model was used to estimate HIV incidence in countries included/excluded from voluntary licenses for LEN and CAB-LA. Worldwide sales of CAB-LA in 2024 were combined with…

←1
234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253
…5455565758…
596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top